Tazarotene Recruiting Phase 4 Trials for Psoriasis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04119102Duobrii in Combination With Biologics